Substituted 8, 8A-dihydro-3AH-indeno(1,2-D)thiazoles , a method for their production and their use as medicaments

Details for Australian Patent Application No. 2001231731 (hide)

Owner Aventis Pharma Deutschland GmbH

Inventors Bickel, Martin; Gossel, Matthias; Lang, Hans-Jochen; Jaehne, Gerhard

Agent Watermark

Pub. Number AU-B-2001231731

PCT Pub. Number WO01/62745

Priority 10008274 23.02.00 DE

Filing date 12 February 2001

Wipo publication date 3 September 2001

Acceptance publication date 7 April 2005

International Classifications

C07D 277/60 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/425 - Thiazoles

Event Publications

7 April 2005 Application Accepted

  Published as AU-B-2001231731

4 August 2005 Standard Patent Sealed

21 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001231732

2001231730